Risperidone Maintenance Treatment in Schizophrenia: A Randomized, Controlled Trial

Abstract

Patients who continued to receive the full risperidone dose used for their acute episode had fewer relapses than those who had dose reductions after 4 weeks or 26 weeks during the maintenance period. There was negligible difference in side effects among the three groups.